Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
JAMA
|
January 23, 1998
Making the most of Pap testing
A M Garber
Annals of Internal Medicine
|
May 20, 2000
Using cost-effectiveness analysis to target cholesterol reduction
A M Garber
Journal of Christian Nursing : a Quarterly Publication of Nurses Christian Fellowship
|
March 27, 2002
Footsteps on a rocky path
A M Garber
Health Affairs (Project Hope)
|
January 1, 1994
Can technology assessment control health spending?
A M Garber
The American Journal of Medicine
|
February 17, 1997
Cholesterol screening should be targeted
A M Garber
Annals of Internal Medicine
|
October 15, 1989
Where to draw the line against cholesterol
A M Garber
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 16, 1999
Realistic rigor in cost-effectiveness methods
A M Garber
The New England Journal of Medicine
|
December 3, 1992
No price too high?
A M Garber
Pharmacoeconomics
|
January 8, 1994
Benefits versus profits: has the orphan drug act gone too far?
A M Garber
Tecnologica (Chicago, Ill.)
|
December 9, 1995
Cost-effectiveness analysis as a measure of value
A M Garber
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
JAMA
|
January 23, 1998
Making the most of Pap testing
A M Garber
Annals of Internal Medicine
|
May 20, 2000
Using cost-effectiveness analysis to target cholesterol reduction
A M Garber
Journal of Christian Nursing : a Quarterly Publication of Nurses Christian Fellowship
|
March 27, 2002
Footsteps on a rocky path
A M Garber
Health Affairs (Project Hope)
|
January 1, 1994
Can technology assessment control health spending?
A M Garber
The American Journal of Medicine
|
February 17, 1997
Cholesterol screening should be targeted
A M Garber
Annals of Internal Medicine
|
October 15, 1989
Where to draw the line against cholesterol
A M Garber
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
October 16, 1999
Realistic rigor in cost-effectiveness methods
A M Garber
The New England Journal of Medicine
|
December 3, 1992
No price too high?
A M Garber
Pharmacoeconomics
|
January 8, 1994
Benefits versus profits: has the orphan drug act gone too far?
A M Garber
Tecnologica (Chicago, Ill.)
|
December 9, 1995
Cost-effectiveness analysis as a measure of value
A M Garber
Page
of 6